Asymmetric Synthesis of a Key Dextromethorphan Intermediate and Its Analogues Enabled by a New Cyclohexylamine Oxidase: Enzyme Discovery, Reaction Development, and Mechanistic Insight
作者:Xiaofan Wu、Zedu Huang、Zexu Wang、Zhining Li、Jiaqi Wang、Juan Lin、Fener Chen
DOI:10.1021/acs.joc.0c00469
日期:2020.4.17
antitussives. We report here that a new cyclohexylamine oxidase discovered by genome mining, named CHAOCCH12-C2, was able to completely deracemize 100 mM 1a under Turner’s deracemization conditions to afford (S)-1a in 80% isolated yield and 99% ee at a semipreparative scale (0.4 mmol). When this biocatalytic reaction was scaled up to a gram scale (5.8 mmol), without reaction optimization (S)-1a was still
(小号)-1-(4-甲氧基苄基)-1,2,3,4,5,6,7,8-全octahydroisoquinoline [(小号)-1-(4-甲氧基苄基)-OHIQ,(小号) - 1A ]是右美沙芬工业生产中的关键合成中间体,右美沙芬是最广泛使用的非处方镇咳药之一。我们在这里报告,通过基因组挖掘,名叫晁发现了一个新的环己胺氧化酶CCH12-C2,能够完全deracemize 100毫米1A特纳去外消旋条件下得到(小号) - 1A在80%的分离产率和99%EE在半制备规模(0.4毫摩尔)。当此生物催化反应放大至克级(5.8 mmol),而没有优化反应(S)-1a仍以67%的收率和96%的ee分离。确定CHAO CCH12-C2相对较高的k cat是使该酶能够在升高的底物浓度下有效氧化1a的主要因素之一。蛋白质序列比对,分析我们与产物1-(4-甲氧基苄基)-3,4,5,6,7,8-六氢异喹啉[1-(4-甲氧基苄基)-复合的CHAO